Tuija Hemmilä
Publications
- Voriconazole greatly increases the exposure to oral buprenorphine (2018)
- European Journal of Clinical Pharmacology
(Refereed journal article or data article (A1)) - Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects (2016)
- Pharmacology Research and Perspectives
(Refereed journal article or data article (A1)) - Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction (2016)
- European Journal of Clinical Pharmacology
(Refereed journal article or data article (A1)) - Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions (2012)
- Pain Practice
(Article or data-article in scientific journal (B1)) - Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects (2011)
- European Journal of Clinical Pharmacology
(Refereed journal article or data article (A1))